| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $9.9M | -0.3% |
| Cost of Revenue | $3.3M | +0.5% |
| Gross Profit | $6.6M | -0.7% |
| R&D Expense | $559K | -43.2% |
| SG&A Expense | $7.6M | -10.1% |
| Operating Income | -$7.7M | +50.0% |
| Pre-tax Income | -$9.0M | +39.5% |
| Income Tax | $10K | +103.2% |
| Net Income | -$9.0M |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $3.8M | -40.6% |
| Accounts Receivable | $4K | -68.1% |
| Inventory | $1.0M | -10.9% |
| Current Assets | $5.3M | -33.7% |
| Total Assets | $14.2M | -16.4% |
| Current Liabilities | $2.0M | -1.2% |
| Total Liabilities | $2.0M | -3.6% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$4.3M | +1.4% |
| Capital Expenditures | $26K | -52.1% |
| Investing Cash Flow | -$1.5M | -6.3% |
| Financing Cash Flow | $3.1M | -38.1% |
| Free Cash Flow | -$4.3M | +2.0% |
| +38.1% |
| EPS (Basic) | -$14.65 | -25.6% |
| EPS (Diluted) | -$14.65 | -25.6% |
| Stockholders' Equity |
| $10.4M |
| -20.8% |